Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2025-12-29 @ 3:52 AM
Study NCT ID:
NCT04984434
Status:
UNKNOWN
Last Update Posted:
2021-07-30
First Post:
2021-07-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Shandong New Time Pharmaceutical Co., LTD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-21
First Submit QC Date:
None
Study First Post Date:
2021-07-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-21
Last Update Post Date:
2021-07-30
Last Update Post Date Type:
ACTUAL